These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24524099)

  • 1. International Association for the Study of Lung Cancer - 15th World Conference on Lung Cancer (October 27-31, 2013 - Sydney, Australia).
    Walker K
    Drugs Today (Barc); 2013 Dec; 49(12):803-8. PubMed ID: 24524099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).
    Rabasseda X
    Drugs Today (Barc); 2015 Sep; 51(9):559-67. PubMed ID: 26488035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological transformation from non-small cell to small cell lung carcinoma.
    Haruta Inoue Y; Kataoka Y; Nikaido J; Nakajima N
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27543609
    [No Abstract]   [Full Text] [Related]  

  • 4. First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?
    Einhorn LH
    J Clin Oncol; 2008 Jul; 26(21):3485-6. PubMed ID: 18506022
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bevacizumab in thoracic oncology: results and practical aspects].
    Dansin É; Cousin S; Lauridant G; Mennecier B
    Rev Pneumol Clin; 2013 Jun; 69(3):159-69. PubMed ID: 23597632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy of non-small-cell lung carcinoma.
    Tiwari D; Brodie SA; Brandes JC
    Ther Adv Respir Dis; 2012 Feb; 6(1):41-56. PubMed ID: 21730004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World conference on lung cancer.
    Felip E; Rosell R
    Expert Opin Biol Ther; 2003 Dec; 3(8):1295-8. PubMed ID: 14640956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights in NSCLC From the IASLC (International Association for the Study of Lung Cancer) 14th World Conference on Lung Cancer.
    Herbst RS
    Clin Adv Hematol Oncol; 2011 Sep; 9(9 Suppl 23):1-24. PubMed ID: 22362179
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting apoptosis pathways in lung cancer.
    Pore MM; Hiltermann TJ; Kruyt FA
    Cancer Lett; 2013 May; 332(2):359-68. PubMed ID: 20974517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel agents in the treatment of lung cancer: conference summary statement.
    Lynch TJ; Adjei AA; Bunn PA; DuBois RN; Gandara DR; Giaccone G; Govindan R; Herbst RS; Johnson BE; Khuri FR; Perez-Soler R; Rosell R; Rowinsky EK; Sandler AB; Scagliotti GV; Schiller JH; Shapiro GI; Socinski MA; Hart CS
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4199s-4204s. PubMed ID: 15217958
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy in non-small cell lung cancer: a standard approach?
    Felip E
    Tumori; 2000; 86(5 Suppl 1):S51-5. PubMed ID: 11195296
    [No Abstract]   [Full Text] [Related]  

  • 12. Pravastatin has no advantage in small-cell lung cancer.
    Brower V
    Lancet Oncol; 2017 Apr; 18(4):e204. PubMed ID: 28285843
    [No Abstract]   [Full Text] [Related]  

  • 13. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.
    Zhang K; Yuan Q
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative thoracic radiotherapy for lung cancer.
    Kepka L; Olszyna-Serementa M
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):559-69. PubMed ID: 20397921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line treatment for advanced non-small cell lung cancer: how to design a clinical trial for a new agent?
    Paesmans M; Berghmans T; Sculier JP
    Lung Cancer; 2007 Feb; 55(2):135-6. PubMed ID: 17118490
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted therapy in small cell lung cancer: A new era?
    Capelletto E; Mariniello A; Novello S
    Lung Cancer; 2017 Jun; 108():252-253. PubMed ID: 28343730
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-small cell lung cancer: from targeted therapy to tailored therapy.
    Malgieri S; Feliciano S; Bosso D; Federico P; Palmieri G; De Placido S; Di Lorenzo G; Buonerba C
    Expert Opin Pharmacother; 2012 Sep; 13(13):1817-9. PubMed ID: 22803703
    [No Abstract]   [Full Text] [Related]  

  • 18. Histology-based treatment: a new scenario in the management of advanced nonsmall cell lung cancer.
    Gridelli C
    Curr Opin Oncol; 2009 Mar; 21(2):97-8. PubMed ID: 19532008
    [No Abstract]   [Full Text] [Related]  

  • 19. Forty years of the international association for study of lung cancer pathology committee.
    Tsao MS; Travis WD; Brambilla E; Nicholson AG; Noguchi M; Hirsch FR;
    J Thorac Oncol; 2014 Dec; 9(12):1740-9. PubMed ID: 25393791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New chemotherapeutic agents in non-small-cell lung cancer.
    Feigal EG; Christian M; Cheson B; Grever M; Friedman MA
    Semin Oncol; 1993 Apr; 20(2):185-201. PubMed ID: 7683142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.